Together In Parkinson's | Exploring Clinical Trials: Debunking Myths and What to Know Featuring Stephanie Farrell, MBA, RN, CCRC, CPHQ

Exploring Clinical Trials: Debunking Myths and What to Know

This conversation focuses on the significance of clinical trials in the context of Parkinson's disease, featuring insights from Stephanie Farrell, Director of Research Administration at Eisenhower Health. The discussion covers the importance of clinical trials, the different types and phases of research, the informed consent process, and the risks and benefits of participation. It also addresses common myths about clinical trials, the patient experience, and the costs associated with participation. The conversation emphasizes the need for patient advocacy and the importance of understanding disease progression alongside potential treatments.

Click here to view transcript

Chapters

00:00 | Introduction to Clinical Trials and Research

03:11 | Importance of Clinical Trials

05:46 | Types of Clinical Research

07:48 | Phases of Clinical Trials

11:31 | Risks and Benefits of Participation

16:20 | Informed Consent Process

19:53 | Myths and Misconceptions about Clinical Trials

22:43 | Randomization in Clinical Trials

26:05 | Patient Experience in Clinical Trials

31:11 | Making Informed Treatment Decisions

36:18 | Costs Associated with Clinical Trials

39:47 | Encouraging Local Clinical Trials

49:53 | Importance of Understanding Disease Progression

Looking for Clinical Trials?

Check these out:

ClinicalTrials.gov

ResearchMatch.org

Eisenhower Health Clinical Trials

Takeaways

• Clinical trials are essential for drug and device approval.
• Every drug available today has undergone clinical trials.
• Patient safety is prioritized in all clinical trials.
• Informed consent is a thorough process for participants.
• Placebos are rarely used in treatment trials.
• Patients can withdraw from trials at any time.
• Participation in trials offers access to new treatments.
• Costs associated with trials may not be fully covered.
• Patients should advocate for local clinical trials.
• Understanding disease progression is as important as finding cures.

About Stephanie Farrell

Stephanie Warner Farrell has a diverse work experience spanning multiple industries. Stephanie started their career in 1993 at Eisenhower Medical Center, where they worked as a Human Resources Generalist and later as a Systems Analyst, responsible for managing various systems. In 1998, they joined Accelerated Technology Solutions, Inc. as a Senior Project Manager, leading a PeopleSoft implementation. In 2000, Stephanie joined Commerce One as a Services Manager. Since 2003, Stephanie has been working at Eisenhower Medical Center in various roles, including Director of Quality/Risk Management/Infection Control, Coordinator of Clinical Cancer Research, and Director of Research Administration. Their work at Eisenhower Medical Center involved managing lung screening programs, coordinating clinical trials, ensuring regulatory compliance, and overseeing quality and risk management.

Stephanie Farrell earned a Bachelor's Degree in Nursing from California State University-San Bernardino from 2011 to 2014. Stephanie also obtained an MBA in Information Systems from the same university from 1996 to 1998. Before that, Stephanie achieved a BA in Business Administration and Management, General from California State University-San Bernardino from 1989 to 1993. In addition to their degrees, they hold various certifications including Registered Nurse (RN) from the Board of Registered Nurses - California (obtained in 2014), Certified Clinical Research Coordinator (CCRC) from the Association of Clinical Research Professionals (obtained in 2007), and Certified Professional in Healthcare Quality (CPHQ) from the National Association of Healthcare Quality (obtained in 2006).

Image Gallery